Back to Top Skip to main content

DoD Establishes Collaborative Virus Genetic Sequencing Capability for COVID-19

Image of two scientists in masks looking at a computer monitor Research associate Lindsay Glang and senior bioinformatics analyst Gregory Rice sequencing SARS-CoV-2 genomes on Oxford Nanopore MinION platform at NMRC BDRD. (Photo Courtesy of Naval Medical Research Center, Genomics & Bioinformatics Department.)

Recommended Content:

Armed Forces Health Surveillance Branch | Coronavirus | Global Emerging Infections Surveillance

As the pandemic continues to unfold, genetic sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus Disease 2019 (COVID-19), has played a critical role in the public health response, including in the design of diagnostics and vaccines. Within the Department of Defense, SARS-CoV-2 genetic sequence data plays a vital role in force health protection efforts.

To jumpstart the DoD’s SARS-CoV-2 sequencing efforts, Armed Forces Health Surveillance Branch’s Global Emerging Infections Surveillance (GEIS) section used its existing partnerships with Army, Navy, and Air Force public health and medical research laboratories. This connection helped to establish a collaborative approach to the sequencing capabilities. Sequence data from this collaboration will provide critical information about transmission patterns, track diagnostic effectiveness, and guide the development and evaluation of medical countermeasures for the 1.4 million active duty and 331,000 reserve personnel.

“GEIS-funded surveillance provides near-real time understanding of how the SARS-CoV-2 virus is evolving. This information is critical for the development of a vaccine and treatment,” stated Navy Capt. Guillermo Pimentel, GEIS chief. “Previous investments by GEIS in this technology have given our partners the capability to respond and sequence SARS-CoV-2 genomes isolated from DoD Service members around the world.”

In 2017, GEIS established a Next Generation Sequencing and Bioinformatics Consortium to work with GEIS partner DoD laboratories to coordinate and improve pathogen sequencing and analysis efforts around the world. Consortium partners can rapidly detect and characterize known, emerging, and novel infectious disease agents using data from pathogen sequencing. This helps to inform force health protection decision making. The core Consortium partners include: the Naval Medical Research Center (NMRC), U.S. Army Medical Research Institute of Infectious Diseases, Walter Reed Army Institute of Research, U.S. Air Force School of Aerospace Medicine, and the Naval Health Research Center.

“We have used virus sequence data in numerous studies to track virus transmission [such as dengue and influenza],” said Irina Maljkovic Berry, chief of Viral Genetics and Emerging Diseases for the WRAIR Viral Diseases Branch in Silver Spring, Maryland. “We estimate outbreak origins to detect and track vaccine escape and other important mutations throughout the world to aid in vaccine design.”

Consortium partners played a key role in analyzing previous viral outbreaks, such as Ebola in West Africa and Zika in South America, and in seasonal influenza vaccine selection. "Each year we generate thousands of influenza genomes that we use to determine how influenza is evolving or evading our vaccines which directly impact our forces," said Clarise Starr, deputy chief of Pathogen Detection and Therapeutics Portfolio Applied Technology and Genomics Division, U.S. Air Force School of Aerospace Medicine. "These efforts will be the same essential practices that we'll need to deploy in response to SARS-CoV-2."

This open partnership and investment proved extremely helpful in response to the COVID-19 pandemic. DoD laboratories quickly established the ability to isolate the virus, share samples, and compare laboratory methods to improve their sequencing capabilities. “We have been evaluating a few different laboratory sequencing protocols to determine which one works best for samples with certain attributes, in order help increase the efficiency of SARS-CoV-2 sequencing from swabs,” according to Kimberly Bishop-Lilly, head of Genomics & Bioinformatics Department at NMRC in Fort Detrick, Maryland.

The sequence data that's being collected is a valuable source of information to better understand virus transmission patterns among DoD personnel, particularly when combined with other clinical and epidemiological data. These data are also compared to global virus sequence data.

“The goal is to have data and information that could help answer how local outbreaks may have started, how SARS-CoV-2 may have spread in a community or geographic area, and how we can better contain spread or improve interventions,” said Lindsay Morton, GEIS’s senior molecular epidemiologist. Thus far, SARS-CoV-2 sequence data has been gathered from infected personnel at more than 25 locations across the globe.

Additionally, GEIS partners are leveraging this technology to improve understanding of global circulation of SARS-CoV-2 through surveillance programs at DoD overseas labs, such as in Thailand, Peru, Kenya, and Cambodia.

“The OCONUS (Outside Continental United States) labs are starting to stand up SARS-CoV-2 sequencing capabilities and the core labs of the Consortium are providing them reach-back support for sequencing protocols and for bioinformatics analyses,” said Bishop-Lilly. “Consensus viral genomes are being produced at some of the OCONUS labs and we are comparing to viral genomes obtained from samples in other regions such as the U.S., to identify what lineage is predominant in a given geographic region and what key genetic variations may be predominant in a certain area.”

These data will provide a better understanding of transmission in these locations and result in a better understanding of risk to U.S. forces deployed around the world as the COVID-19 pandemic continues. GEIS leaders hope that increased collaboration across the agencies will propel the research and production of an effective vaccine.

“The key to fully utilizing SARS-CoV-2 sequence data is collaboration,” said Morton, “Consortium partners are ready and willing to engage with organizations involved with clinical studies and outbreak investigations across the DoD to better guide the Department’s response to COVID-19 and reduce the impact to readiness and operations around the world.”

You also may be interested in...

LTG Place Vaccine Roll-Out Video

Video
1/18/2021
DHA Seal

DHA Director LTG Ron Place talks about coronavirus vaccines, their safety and efficacy, and encourages everyone to do their own research to get vaccinated.

Recommended Content:

COVID-19 Toolkit | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

COVID-19 hinders blood donations during National Blood Donor Month

Article
1/14/2021
Navy Capt. R. Wade Blizzard, commanding officer of U.S. Navy Support Facility Diego Garcia, donates blood for the Navy Medicine Readiness and Training Units Diego Garcia walking blood bank on Dec. 17, 2020. The walking blood bank is a list of eligible donors who can provide blood in case of emergency. (U.S. Navy photo by Navy Seaman Apprentice Stevin Atkins)

Life-saving blood is in high-demand by the Armed Services Blood Program, as the COVID-19 has negatively impacted donations.

Recommended Content:

Armed Services Blood Program | Public Health | Coronavirus | Holiday Observances

Partnerships, COVID-19 are catalysts for enterprise virtual health

Article
1/14/2021
Image of Mr. Adler with text: "Partnerships, COVID-19 are catalysts for enterprise virtual health."

Jamie Adler, the lead for the DHA’s Virtual Health Clinical Integration Office, discusses the future of virtual health (VH).

Recommended Content:

Coronavirus | Connected Health | COVID-19 Vaccine Toolkit

COVID presents new set of challenges for DOD environmental health

Article
1/12/2021
Group of Marines, snowshoeing through the snow

One of the most important factors to take into account when maintaining one’s overall fitness is physical environment.

Recommended Content:

Total Force Fitness in a Pandemic | Reintroducing Total Force Fitness | January Toolkit | Coronavirus | COVID-19 Vaccine Toolkit | Total Force Fitness

DOD Launches “My MilLife Guide” Text Message Program to Boost Wellness

Article
1/11/2021
The new My MilLife Guide program supports the wellness of the military community.

DoD has launched My MilLife Guide, a new program that sends text messages designed to help the military community boost overall wellness while navigating stresses related to COVID-19.

Recommended Content:

Coronavirus | Public Health | Total Force Fitness | Health Readiness

Navy corpsman provides multitude of support to hospital

Article
1/8/2021
Two military personnel, wearing masks, in a supply room looking at the shelves

“Thinking outside the box is what makes a great person, let alone a Sailor," Tie said.

Recommended Content:

Public Health | Coronavirus

MTF facilities, markets set to resume transition heading into 2021

Article
1/6/2021
A military nurse, wearing a mask, prepares a needle for a vaccination

Butler says transition on track.

Recommended Content:

MHS Transformation | Coronavirus

BACH healthcare workers and first responders vaccinated for COVID-19

Article
1/6/2021
Soldier gives a nurse a vaccine in her left arm

BACH now joins other Defense Health Agency military treatment facilities that have received the vaccine, marking the start of a phased-in vaccination program to mitigate the spread of the virus.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Toolkit

COVID-19 Vaccine Toolkit

Publication
1/5/2021

This toolkit provides communicators across the Military Health System (MHS) with important information about the COVID-19 prevention and vaccination from the CDC to share with patients and health care professionals.

Recommended Content:

Coronavirus | COVID-19 Information for Military Treatment Facility Directors | COVID-19 Vaccine Efforts | COVID-19 Toolkit

COVID-19 Social Media Toolkit

Publication
1/5/2021

These messages are provided for you to use on your platforms with any of the images from the COVID-19 Toolkit.

Recommended Content:

Coronavirus

Countering seasonal depression during the COVID-19 pandemic

Article
1/5/2021
Man with his head in his hands, sitting in front of a Christmas tree

SAD, or sometimes called seasonal depression, is a subtype of a major depressive disorder.

Recommended Content:

Coronavirus | Psychological Fitness | Depression | Suicide Prevention

MHS operational innovations continue in battle against COVID-19

Article
1/5/2021
Two medical personnel, wearing full PPE, in an operating room

MHS innovations in 2020 include a new registry for real-time COVID-19 data and a system to free up hospital beds and protect patients from the disease.

Recommended Content:

Coronavirus | Research and Innovation | Innovation | Technology | COVID-19 Vaccine Toolkit

Remote monitoring program enables COVID-19 patients to recover at home

Article
1/4/2021
Two medical personnel, wearing masks, looking at the contents of a home-based COVID treatment kit

The program equips COVID-19 patients needing additional monitoring with a home healthcare kit and 24/7 oversight from registered nurses to ensure a higher level of post-hospital care.

Recommended Content:

Public Health | Coronavirus | Innovation

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

<< < ... 6 7 8 9 10  ... > >> 
Showing results 76 - 90 Page 6 of 40

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.